CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers & Opportunities
4.1.1. Increasing number of minimally invasive vascular surgeries
4.1.2. Enlargement of target patient population base
4.1.3. Favourable reimbursement scenario for minimally invasive surgeries
4.1.4. Clinical evidence for safety and efficacy of occlusion devices
4.1.5. Focus on expansion of manufacturing & distribution capabilities
4.1.6. Increasing healthcare expenditure across developing economies
4.2. Market Restraints & Challenges
4.2.1. Stringent regulatory framework for product commercialisation
4.2.2. Procedural limitations associated with CTO treatment
4.3.1. Lack of skilled surgeons
CHAPTER 5. GLOBAL OCCLUSION DEVICES MARKET – BY PRODUCT
5.1. Tubal Occlusion Devices
5.2. Embolization Devices
5.2.1. Liquid Embolic Agents
5.2.2. Embolic Coils
5.3. Occlusion Removal Devices
5.3.1. Stent Retrievers
5.3.2. Coil Retrievers
5.3.3. Balloon Occlusion Devices
5.3.4. Suction & Aspiration Devices
5.4. Support devices
5.4.1. Guidewires
5.4.2. Microcatheters
5.5. Others
CHAPTER 6. GLOBAL OCCLUSION DEVICES MARKET – BY APPLICATION
6.1. Urology
6.2. Neurology
6.3. Peripheral Vascular Disease
6.4. Cardiology
6.5. Gynaecology
6.6. Oncology
6.7. Others
CHAPTER 7. GLOBAL OCCLUSION DEVICES MARKET – BY END USER
7.1. Research Laboratories & Academic Institutes
7.2. Hospitals, Diagnostic Centers, and Surgical Centers
7.3. Ambulatory Care Centers (ACCS)
7.4. Others
CHAPTER 8. GLOBAL OCCLUSION DEVICES MARKET - BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. APAC
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9. GLOBAL OCCLUSION DEVICES MARKET - COMPANY PROFILES
9.1. Terumo Corporation
9.2. Acrostak AG
9.3. Stryker Corporation
9.4. Asahi Intecc Co., Ltd.
9.5. Avinger, Inc.
9.6. Medtronic PLC
9.7. B. Braun Melsungen, Ltd.
9.8. Cardinal Health, Inc.
9.9. Abbott Laboratories, Pvt. Ltd.
9.10. C.R. Bard, Inc.
9.11. Boston Scientific
9.12. Penumbra, Inc.
CHAPTER 10. GLOBAL OCCLUSION DEVICES MARKET - COMPETITIVE
LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11. MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12. APPENDIX
12.1. List of Tables
12.2. List of Figures
